Stock Events

Stock Events

KalVista Pharmaceuticals (KALV) Q3 2024 Earnings

11JulConfirmed

Q2 2023

Q3 2023

Q1 2024

Q3 2024

-1.02

-0.92

-0.82

-0.71

Details

Expected EPS

-0.712633

Actual EPS

-1.02

Surprise EPS

-0.31

Surprise Percent

+43.13%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -1.02 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.